CClinicalTrials.gg
CompletedNCT06790953Updated Feb 4, 2025

Efficacy of Novel Titania Nanoparticles Enriched Mouth Wash in Treating Dentine Hypersensitivity

An interventional study of Group- A Conventional Sensed Mouth Wash and Group-B Novel Titania nanoparticles enriched Mouth Wash in Dentine Hypersensitivity, sponsored by Pakistan Institute of Medical Sciences. Completed at 1 site in Pakistan. Open to participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-04.

Sponsored by Pakistan Institute of Medical Sciences · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Jun 2024, registered Jan 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Study summary

Randomized Clinical trial to compare the reduction in dentin hypersensitivity after incorporating biogenically fabricated titania nanoparticles enriched Mouth Wash and Conventional Mouth Wash.Participants ranging between 20-50 years were allocated in two groups. Group A will use Conventional Mouth Wash without Nanoparticles. Group B will use titania nanoparticles enriched Mouth Wash. Both will use them for three months and then their VAS scoring will be checked.

Read the detailed description

In this study Novel biogenically fabricated titania nanoparticle reinforced Mouth Wash will be evaluated for dentine sensitivity . Participants following Inclusion criteria will be allocated in this study by Consecutive random sampling technique. Participants will be divided into two groups i.e Group-A and Group-B with dentin sensitivity of 30-80. Group A will be given Conventional Mouth Wash for three months and Group-B will be given titania nanoparticles enriched Mouth Wash for three months for the sensitivity. Sensitivity will be assessed using Visual analog scale (VAS) mean score after 1 month and then three months.

02

Conditions studied

  • Dentine Hypersensitivity

Keywords

  • Bacillus coagulans
  • Biogenic
  • Dentin Hypersensitivity
  • Nanoparticles
  • Titanium oxide (TiO2 Nps)
03

In context

Dentin Sensitivity

283 studies on the registry are indexed under Dentin Sensitivity; 45 are open to participants now.

This study's enrollment of 130 is above the median of 60 across 274 interventional studies indexed under Dentin Sensitivity.

Browse Dentin Sensitivity studies →

Lead sponsor

Pakistan Institute of Medical Sciences is the lead sponsor of 51 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participants ranging between 20-50 years, good general health but developed dentine sensitivity associated with tooth surface wear and loss during the past 6 months.
  • There was no history of allergy.
  • Participants did not use any mouth wash , dentifrice or medication in the last 3 months.
  • The involved teeth were viable, non-shaky, devoid of any decay, cracks and fillings.
  • There was an essential positive response to the provoking Air stimuli.
  • These teeth should display the visible signs of tooth loss and wear such as : attrition, abrasion, erosion and abfraction.

Exclusion criteria

Exclusion Criteria:

  • Participants that might have developed allergy or used medications during the last 2 weeks or more.
  • The teeth having cracks, decay and fillings were also excluded. Patients who have undergone any periodontal surgery or gross periodontal issues.
  • Participants who used any desensitisizing toothpastes/mouthwashes and tooth bleaching agents within 2 months of the trial were also excluded positively.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
130 participants (actual)

Study arms

  • Experimental
    Group-A: Conventional Mouth wash .

    Group A will receive conventional mouthwash for treatment of dentin hypersensitivity

    Procedure: Group- A Conventional Sensed Mouth Wash

  • Experimental
    Group-B: Novel Titania nanoparticles Mouth wash

    Group B will receive novel Titania nano particles reinforced mouthwash for treatment of dentin hypersensitivity

    Procedure: Group-B Novel Titania nanoparticles enriched Mouth Wash

Interventions

  • ProcedureGroup- A Conventional Sensed Mouth Wash

    In Group- A Conventional Sensed Mouth Wash will be used for treatment of Dentin hypersensitivity. Visual Analogue scoring system will be used to calculate the dentin hypersensitivity.

  • ProcedureGroup-B Novel Titania nanoparticles enriched Mouth Wash

    In Group-B Novel Titania nanoparticles enriched Mouth wash will be used to treat the Dentin hypersensitivity. Visual Analogue scoring system will be used to calculate the dentin hypersensitivity.

06

What researchers measure

Primary outcomes

  1. Post mouth wash utilization Dentine Hypersensitivity

    Evaluation of dentine hypersensitivity with Conventional Mouth Wash without titania nanoparticles and Novel Nps Mouth Wash with titania nanoparticles on human tooth dentin. Visual analog scale with scoring from 0 to 100 where Score 100 means worst outcomes.

    Time frame: 3 months

07

Study locations

1 site
  • School of Dentistry, Pakistan Institute of Medical Sciences
    Islamabad, Punjab 44080, Pakistan
08

References and documents

Publications

  • Aboelenein AZ, Riad MI, Haridy MF. Effect of a Self-Etch Adhesive Containing Nanobioglass on Postoperative Sensitivity of Posterior Composite Restorations - A Randomized Trial. Open Access Maced J Med Sci. 2019 Jul 25;7(14):2313-2320. doi: 10.3889/oamjms.2019.585. eCollection 2019 Jul 30. PubMed 31592280 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06790953
Lead sponsor
Pakistan Institute of Medical Sciences
Responsible party
Afsheen Mansoor (Principal Investigator, Pakistan Institute of Medical Sciences) — Principal investigator
First posted
Jan 24, 2025
Start date
Jun 13, 2024
Primary completion
Dec 3, 2024
Completion
Dec 3, 2024
Last update
Feb 4, 2025

Study contacts

Afsheen Mansoor, PhD
principal investigator · School of Dentistry, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion